Home » Topics » BioWorld Science

BioWorld Science
RSS

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery identify caspase inhibitors

Aug. 13, 2018

Orphazyme's arimoclomol enters phase III study for ALS

Aug. 13, 2018

FDA approves Galafold for Fabry disease

Aug. 13, 2018

Discovery of a potent and selective receptor antagonist for the treatment of asthma

Aug. 13, 2018

University of Sydney and University of Technology, Sydney patent glycine transport inhibitors

Aug. 13, 2018

Pfizer describes new monoglyceride lipase inhibitors

Aug. 13, 2018

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

MMP23B identified as a putative diagnostic biomarker of bladder cancer

Aug. 13, 2018

Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome

Aug. 13, 2018

Researchers present Fol-PRI-002 as a potential prodrug for oral administration

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...